Evidence map›Paper›PMID 28506631›Full record

ArticleJournal of virological methods2017

Susceptibility of neuroblastoma cells to rabies virus may be affected by passage number.

Craig Pouliott, Michelle Dupuis, Kim Appler, Scott Brunt, Robert Rudd, April Davis

Open access · greenAbstract read
In one paragraph

Article in Journal of virological methods, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Craig PouliottRabies Laboratory, Wadsworth Center, New York State Department of Health, Slingerlands, NY, USA.
Michelle DupuisRabies Laboratory, Wadsworth Center, New York State Department of Health, Slingerlands, NY, USA.
Kim ApplerRabies Laboratory, Wadsworth Center, New York State Department of Health, Slingerlands, NY, USA.
Scott BruntRabies Laboratory, Wadsworth Center, New York State Department of Health, Slingerlands, NY, USA.
Robert RuddRabies Laboratory, Wadsworth Center, New York State Department of Health, Slingerlands, NY, USA.
April DavisRabies Laboratory, Wadsworth Center, New York State Department of Health, Slingerlands, NY, USA. Electronic address: april.davis@health.ny.gov.
New York State Department of Health · USWadsworth Center · US

Funding

Rabies virus maintenance in bat populationsK08AI085031 · NIAID · WADSWORTH CENTER · PI DAVIS, APRIL DAWN · 2010 to 2013
$423k
NIAID NIH HHS K08 AI085031
6 · The paper itself

Abstract

Maintaining a healthy, continuous immortalized cell line is essential for rabies laboratories that perform virus isolation assays and test for the presence of viral neutralizing antibodies. Individuals who routinely work with rabies virus, such as rabies laboratory employees, or those who may have a high potential for exposure to rabies virus, including veterinarians, should be tested for the presence of anti-rabies viral neutralizing antibodies (VNA) every 6-24 months, depending on potential exposure level. The gold standard for serum neutralization assays require the use of live rabies virus and cells that are sensitive to rabies virus infection. Additionally, virus isolation assays are routinely performed in rabies laboratories as a back-up for the direct fluorescent antibody test (dFAT). Currently there are no guidelines or publications recommending the use of low, intermediate, or high passage cell lines in rabies assays. In this study, we compared the sensitivity of intermediate, high, and extremely high passaged neuroblastomas to rabies virus using virus isolation, serum neutralization, and real time RT-PCR techniques. Additionally, cells were examined microscopically to determine changes in morphology and dissemination of rabies virus antigen between intermediate, high, and extremely high passage cells. No significant difference was found between cell passage numbers and viral susceptibility between intermediate and high passaged cells. However, extremely high passaged cells (≥1200 passages) were less susceptible to viral infection and/or produced less virus following inoculation. As a result, rabies laboratories that use viral isolation and serum neutralization assays should regularly assess cell susceptibility to ensure the integrity and repeatability of the test.

Indexed as

Viral TropismCell Line, TumorHumansNeuronsNeutralization TestsRabies virusSerial PassageTissue Culture TechniquesVirus CultivationAntigenCell cultureRabies diagnosisRabies virusViral susceptibility

Identifiers

PMID28506631
PMCPMC5527296
OpenAlexW2612932422

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.